Tom, I would love to be able to reach the same conclusion as you but I am struggling to do so. The one thing I am pretty clear about is that there is a very low probability, that on an net basis, Cogstate will be able to replace the US$ 15 million of healthcare revenue it is giving up in the same time frame. The only way they will be able to do it is with more than one significant partnerships.
I think in retrospect the departure of Brad's wife as the head of healthcare was probably a sign that things were not going to plan with Eisai and Cognigram.
Ann: Eisai and Cogstate Amend Global License Agreement, page-4
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.040(3.20%) |
Mkt cap ! $221.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.29 | $1.26 | $12.17K | 9.555K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1880 | 1 |
View Market Depth
| Last trade - 14.21pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.28 |
Change
0.040 ( 3.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.27 | $1.28 | $1.26 | 1578 | ||
| Last updated 14.21pm 17/05/2024 ? | |||||
| CGS (ASX) Chart |